cemiplimab,nivolumab,ipilimumab
bms,regeneron
['lung', 'nsclc', 'ipilimumab', 'nivo', 'nivolumab', 'cemiplimab', 'sclc']
some updates on lung cancer from the esmo meeting in paris!
martin reck, md, phd, on nsclc: new findings on cemiplimab, nivolumab, and ipilimumab - the asco post 
Working on medicine